LOOKING BEYOND ARTERIAL INTERVENTION IN CLTI PATIENTS

Moderator(s)

• 

  Rabih Chaer, MD, MSc

  Chief, Division of Vascular Surgery
  Stony Brook Medicine
  Vascular Surgery
  Stony Brook, New York, United States

  Disclosure(s): No financial relationships to disclose
• 

  Brian DeRubertis, MD

  Chief, Division of Vascular Surgery
  NewYork-Presbyterian / Weill Cornell Medical Center
  Vascular Surgery
  New York, New York, United States

  Disclosure(s): Abbott Vascular: Advisory Board; Consultant; Grants/Research Support Recipient; Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)
  BD (formerly Bard): Advisory Board; Consultant
  Boston Scientific: Advisory Board; Consultant; Grants/Research Support Recipient
  Cagent: Grants/Research Support Recipient; Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)
  Concept Medical: Advisory Board; Consultant; Grants/Research Support Recipient; Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)
  Medtronic: Advisory Board; Consultant; Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)

Panel(s)

• 

  Marc Bonaca, MD, MPH

  Professor
  University of Colorado
  Vascular Medicine
  Aurora, Colorado, United States

  Disclosure(s): 35Pharma, Inc.; Abbott Labratories; Agios Pharmaceuticals, Inc.; Alexion Pharmaceuticals; Amgen; Anthos Therapeutics, Inc.; Arrowhead Pharmaceuticals; Autonomy Bio, Inc.; Bayer; Bristol-Myers Squibb; Cleerly, Inc.; Cook Regentec: Grants/Research Support Recipient
  Eidos Therapeutics, Inc.; EluraBio, Inc.; Esperion Therapeutics, Inc.; Faraday Pharmaceuticals, Inc.; Gasherbrum Bio, Inc.; Insmed; IsomAb Limited; JanOne Biotech Holdings, Inc.; Janssen Pharmaceuticals, Inc.; Lexicon Pharmaceuticals, Inc.: Grants/Research Support Recipient
  Lilly USA; Medison Pharma; Merck Sharp & Dohme Corp.; Nectero Medical, Inc.; NewAmsterdam Pharma; Novartis Pharmaceuticals; Novo Nordisk, Inc.; Pfizer; Piper Sandler & Co; PPD Development; Prothena Biosciences; Sanofi; Silence Therapeutics: Grants/Research Support Recipient
  Stealth BioTherapeutic, Inc.; Regeneron; Tourmaline Bio, Inc.; VarmX; Verve Therapeutics: Grants/Research Support Recipient
• 

  Scott Boynton, DPM

  Assistant Professor of Surgery
  Oregon Health and Science University
  Podiatry, Oregon, United States

  Disclosure(s): Mimedx: Consultant
• 

  Daniel Clair, MD

  Chair, Department of Vascular Surgery
  Vanderbilt University Medical Center
  Vascular Surgery
  Nashville, Tennessee, United States

  Disclosure(s): BD (formerly Bard): Consultant
  Boston Scientific: Consultant
  Caeli Vascular: Consultant
  Cook Medical: Consultant
  Cordis: Consultant
  Deerfield EGLX Accelerator: Consultant
  Elastimed: Consultant
  Endologix: Consultant
  Inari Medical: Consultant
  LimFlow: Consultant
  Medtronic: Consultant
  NAMSA: Consultant
  Nectero: Consultant
  Penumbra: Consultant
  Pylon Medical: Consultant
  Shockwave: Consultant
  Vesteck: Consultant
• 

  Jennifer Rymer, MD, MBA

  Duke University
  Interventional Cardiology, United States

  Disclosure(s): No financial relationships to disclose

Presentations:

• 1:15pm - 1:22pm PT

  Key Components of Medical Management in the CLTI Population
  

  Speaker: Marc P. Bonaca, MD, MPH – University of Colorado
• 1:22pm - 1:29pm PT

  Frailty and the Importance of Nutrition, Social Support, and Other Factors in Limb Salvage
  

  Speaker: Jennifer Rymer, MD, MBA – Duke University
• 1:29pm - 1:37pm PT

  Panel Discussion
• 1:37pm - 1:44pm PT

  Requirements for a Functional Limb and the Role of Primary Amputation
  

  Speaker: Daniel Clair, MD – Vanderbilt University Medical Center
• 1:44pm - 1:51pm PT

  Podiatric Surgical Adjuncts for Limb Salvage
  

  Speaker: Scott Boynton, DPM – Oregon Health and Science University
• 1:51pm - 2:00pm PT

  Panel Discussion